Pay in 4 interest-free payments of $20.00 Learn more
Ships within 48 hours · Estimated delivery Aug 12 - Aug 17
Formula: C26H31FN7O6P
ClH/c1-12(23)25-18-10-14-11-22(9-8-17(14)26-18)19(20(24)13-6-7-13)15-4-2-3-5-16(15)21
These doses are estimated to provide approximately 0
ATM is involved in cell-cycle control through the regulation of retinoblastoma protein phosphorylation
Chemical Name: 5-(difluoromethoxy)-2-[(3
Edoxaban - CAS# 480449-70-5 somer Formula: C26H31FN7O6PEdoxaban (INN, codenamed DU 176b, trade name Lixiana) is a potent, selective factor Xa inhibitor, which has good oral bioavailability. Edoxaban is an anticoagulant drug which acts as a direct factor Xa inhibitor. It is being developed by Daiichi Sankyo. It was approved in July 2011 in Japan for prevention of venous thromboembolisms (VTE) following lower limb orthopedic surgery. It was also approved by the FDA in January 2015 for the prevention of
US$ 143.00
US$ 143.00
US$ 50.00
US$ 21.00
US$ 83.00
US$ 34.95
US$ 62.00
US$ 116.00
US$ 154.00